Cellect Biotechnology Ltd. - ADR
APOP
Get informed when a big investor buys or sells
+ FollowMarket Cap$129.02M
Close$
$13.51
2.6% upside
Current Fair Value
2.6% upsideUndervalued by 2.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $129.02 Million |
|---|---|
| Enterprise Value | $125.90 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1642266.42 |
| Beta | 1.88 |
| Outstanding Shares | 80,884 |
Return
| Return on Equity | -180161.89% |
|---|---|
| Return on Assets | -100719.75% |
| Return on Invested Capital | 38.16% |
Valuation & Multiples
| P/E Ratio | -0.7 |
|---|---|
| PEG | -2.25 |
| Price to Sales | - |
| Price to Book Ratio | 0.12 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 31.89 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.00% |
|---|---|
| Total Invested | $6 |
| Investors Holding | 10% |
ESG Score
No data
About Cellect Biotechnology Ltd.
CEO: Shai Yarkoni